Similarly, some studies showed that CKD patients with vascular calcification [35,36,37,38,39] and heart valve calcification (p < 0.05) [37,40] had higher serum sclerostin levels compared to noncalcified counterparts, respectively. This evidence concerns the gene SOST and chronic kidney disease.